Jawbone says Fitbit is no longer seeking to block sales of its products
Of course, Jawbone isn't selling that many fitness trackers these days either. — Jawbone said Saturday that one part of its legal battle with Fitbit has been resolved. — In a statement to Recode …
Context & Ripple Effects
This closes a chapter in a fight that began in mid-2015, when Jawbone filed what was then its second suit against Fitbit in two weeks over patent infringement, and Fitbit answered with a countersuit Jawbone called frivolous. The legal momentum had already turned: an ITC judge ruled in April that the Jawbone patents at the center of the case were invalid, gutting the leverage behind any sales ban.
What changed now is that Fitbit has stopped seeking to block Jawbone's product sales outright, resolving one front of the dispute even as Jawbone — which publicly refuted reports it would exit the tracker market earlier in the year — fights for commercial relevance.
First-order effects
- Jawbone keeps its trackers on the market without an import-ban or injunction overhang, removing the existential distribution risk that a successful Fitbit exclusion request would have carried.
- Fitbit frees litigation budget and management attention from a blocking campaign that its own ITC loss had already made unwinnable.
Second-order effects
- With the sales-ban threat gone, competition between the two shifts entirely to product and pricing — a bad arena for Jawbone, whose shrinking tracker volumes were noted even in coverage of the settlement, and a comfortable one for the margin-pressured market leader.
- The outcome weakens the case for other wearable makers to open patent wars as a first resort: the template of suing a dominant rival ended with the challenger's patents invalidated and its rival unblocked.
Third-order effects
- If the pattern holds, hardware patent assertions will be priced by litigants as defensive costs rather than offensive weapons, pushing wearables competition toward software ecosystems and brand rather than courtroom exclusivity.
- For struggling hardware startups, the episode suggests that a patent portfolio is not a moat when a judge can invalidate the core claims — capital may rotate from litigation to differentiation instead.
The trend: Wearables patent wars are collapsing as a competitive strategy, with court-invalidated claims pushing rivals back onto product and ecosystem grounds.